PRESS RELEASE: Akebia Therapeutics to Present at Upcoming Investor Conferences. Details here: https://lnkd.in/ehVTsqcf
Akebia Therapeutics
Biotechnology Research
Cambridge, MA 39,675 followers
We're focused on the development & commercialization of therapeutics for people living with kidney disease.
About us
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease. Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
- Website
-
http://www.akebia.com
External link for Akebia Therapeutics
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Cambridge, MA
- Type
- Public Company
- Founded
- 2007
Locations
-
Primary
245 First Street
Suite 1400
Cambridge, MA 02142, US
Employees at Akebia Therapeutics
Updates
-
* RECRUITMENT FRAUD ALERT* Akebia Therapeutics has received reports of fraudulent job offers and unauthorized individuals posing as Akebia employees in an attempt to obtain personal information from job seekers. These scams may involve communications from email addresses or domains that appear similar to Akebia’s, as well as fake job postings on various websites. Please be aware that Akebia’s official job postings are only listed on our company website and our official LinkedIn page. Any legitimate recruiting correspondence from Akebia will come from a recruiting representative using an **@akebia.com** email address. Akebia will never ask for your personal financial information, such as bank account details or personal identification numbers, at any stage of the interview process. We also do not charge any fees to job seekers as part of our recruitment process. If you receive an unexpected job offer or communication from someone claiming to represent Akebia, please do not respond, do not click on any hyperlinks, and do not open any attachments. If you suspect you have been contacted by an unauthorized person or have received a fraudulent job offer, we recommend that you contact your local law enforcement agency immediately. Your safety and security are important to us. Thank you for your interest in a career with Akebia Therapeutics.
-
PRESS RELEASE - Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference: https://lnkd.in/esbcwiGs
-
-
PRESS RELEASE: Akebia Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights. Link: https://lnkd.in/ek8Bgps4
-
-
Team Akebia on site at #NKFSCM25. We valued the opportunity to connect with peers, share data and discuss the latest treatments for people living with kidney disease. Thank you, National Kidney Foundation, for another productive meeting! Faith Goan, PharmD, Jason Dent, Joe Diaz, Katie Hernandez, MBA, Becky Lopez-Ruiz, Doug Strickland, Donna Jeffers, Ralph Capaldi, Rachel Fox MS, RD, LD, Caitlin Gilbert Beck, Karine M.
-
-
SCM25 #NKFClinicals is here! Join Akebia Medical Affairs at Booth 1221 on Friday, April 11 at 7:30 am to learn about hypoxia-inducible factor activation in anemia due to CKD and the latest clinical research for anemia treatment in patients on dialysis. We hope to see you there!
-
-
It's almost time for National Kidney Foundation SCM2025. Plan ahead to visit Akebia's Commercial and Medical Affairs Teams at Booth #1121 and check out the latest data on display in the poster hall: https://lnkd.in/ed3Z8spf
-
-
SCM25 #NKFClinicals is less than a week away! Check out the Akebia Medical Affairs Exhibitor Showcase at Booth 1221 on Friday, April 11 at 7:30 am to learn about hypoxia-inducible factor activation in anemia due to CKD and our latest clinical research. We hope to see you there!
-
-
We're getting ready for National Kidney Foundation Spring Clinical Meetings 2025 in our own backyard in Boston! We’re eager to connect with the kidney community, review research and discuss the latest treatments for patients. Attending? Visit Akebia at Booth #1121 in the Exhibit Hall.
-
-
Akebia’s Karine M. comments on the value of connection and community among those who treat people living with kidney disease: "Advancing kidney care requires collaboration and meaningful engagement with the medical community. Physician engagement and education help ensure patients with chronic kidney disease receive the best possible care. By fostering peer-to-peer connection and meaningful conversations, we can help educate healthcare providers to enable them to make the best treatment decisions for their patients."
-